1-(Methylthio)ethanethiol
Common Name: |
1-(Methylthio)ethanethiol |
IUPAC Name: |
1-methylsulfanylethanethiol |
Molecular Formula: |
C5H8OS |
SMILES: |
CC(S)SC |
Inchi: |
1S/C3H8S2/c1-3(4)5-2/h3-4H,1-2H3 |
Inchi Key: |
GHIADNFHCKUPJL-UHFFFAOYSA-N |
Cas No: |
31331-53-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
3 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
116.18 |
Mass (g/mol) |
108.007 |
Molar Refractivity |
32.58 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
|
TPSA |
48.03 |
Hetero Atoms |
2 |
Heavy Atoms |
7 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
131.00 to 132.00 |
Vapor Pressure (mmHg@25.00 °C) |
10.66 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
1.625 |
iLOGP |
1.91 |
XLOGP3 |
1.04 |
WLOGP |
1.57 |
MLOGP |
0.62 |
ESOL Log S |
-1.22 |
ESOL Solubility (mg/ml) |
7.07 |
ESOL Solubility (mol/l) |
0.061 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-1.64 |
Ali Solubility (mg/ml) |
2.67 |
Ali Solubility (mol/l) |
0.02 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-1.14 |
Silicos-IT Solubility (mg/ml) |
8.36 |
Silicos-IT Solubility (mol/l) |
0.07 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.27 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.575 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
3.493 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |